Brooks Laboratories Rights Issue will open for subscription from 07 August 2023. the company aims for an issue size of ₹11.58 Crores through this rights Issue.
About the company
Incorporated in 2002, Brooks Laboratories Limited is engaged in the manufacturing and marketing of pharmaceuticals nationally as well as at the international level. The company has its own manufacturing facility located at Baddi, Himachal Pradesh. A Research and Development driven Pharmaceutical manufacturing company proffering a variety of solutions to customers.
Brooks Laboratories is a Pharmaceutical Contract Research and Manufacturing Services entity. They offer a wide range of products specifically catering to the critical care segment in the Parental Section. The offerings include Beta Lactam, Ampoules and Liquid vials, General Dry powder Injectables, Dry Syrups, and Tablets.
The products range includes:
- Liquid Injection
- Dry Powder Injection
- Tablets
- Oral Suspension
With a motivated team of highly qualified professionals, the company is working to stabilize new molecules in niche segments, in order to offer stable latest products to the end customers.
Objectives of the Issue
- Coming soon
Brooks Laboratories Rights Issue Timetable
| Last Date to buy shares | 27 July 2023 |
| Record Date | 28 July 2023 |
| Credit of Rights Entitlements | 03 August 2023 |
| Bid/Offer Opens On | 07 August 2023 |
| Renunciation of Rights Entitlements | 17 August 2023 |
| Bid/Offer Closes On | 22 August 2023 |
| Deemed Date of Allotment | 29 August 2023 |
| Credit Date | 30 August 2023 |
| Listing Date | 01 September 2023 |
Brooks Laboratories Rights Issue Details
| Issue Open | Aug 7, 2023 – Aug 14, 2023 |
| Security Name | Brooks Laboratories Limited |
| Issue Size (Shares) | 1,543,926 |
| Issue Size (Amount) | ₹11.58 Crores |
| Issue Price | ₹75 per share |
| Face Value | ₹10 per share |
| Listing At | BSE |
| Terms of Payment | Full amount of Rs. 75 for rights equity shares has to be paid on application. |
| Entitlement | 1 Rights Equity Share(s) for every 16 fully paid-up Equity Shares held on Record Date |
Company Financials
| Period Ended | Total Revenue | Profit After Tax |
|---|---|---|
| 31-Mar-22 | 91.99 | -18.31 |
| 31-Mar-23 | 63.41 | -31.05 |
Rights Issue Documents
- Coming soon
Lead Manager(s)
Coming soon
Rights Issue Registrar
Coming soon
Company Contact Information
Brooks Laboratories Limited
Vill.Kishanpura,
Nalagarh Road,
Baddi – 174101
Phone: +91-1795 – 236939
Email: investors@brookslabs.net
Website: https://www.brookslabs.net/
Final Thoughts
Applying for the rights issue is purely a personal choice. make sure you make a detailed study about the company and rights issue before you make an investment decision.
Happy investing
